Indolyl Heterocycle Sperm Activators for Cryopreserved Boar Semen

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Cryopreservation of boar sperm leads to decreased sperm motility, viability, and fertility due to temperature sensitivity, resulting in lower fertilization rates and economic losses for the pork industry, as existing extenders do not enhance sperm motility effectively.

Innovation Solution

The use of specific compounds, such as 5-(1H-indol-3-yl)-oxazole, -oxadiazole, and -furan derivatives, as sperm activators to enhance sperm motility and fertility in boar semen, even after cryopreservation or storage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If cryopreservation is used to store boar sperm for extended periods, then storage duration is improved, but sperm motility and viability deteriorate

Engineering Contradiction:
Improvestorage durationVSAvoidsperm motility and viability
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent applies preliminary action by adding specific compounds (such as caffeine, theophylline, or other phosphodiesterase inhibitors) to the sperm sample before storage or before use. These compounds are pre-introduced to maintain sperm motility and viability throughout the storage period, counteracting the damaging effects of cryopreservation beforehand rather than attempting to repair damage after storage.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses chemical compounds as intermediaries between the sperm and the cryopreservation process. These compounds (e.g., phosphodiesterase inhibitors) act as mediators that protect sperm cells from the harmful effects of freezing and storage, maintaining intracellular cAMP levels and preventing motility loss without directly altering the sperm structure or requiring complex equipment modifications.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If cryopreservation is used to enable sperm transport and storage, then adaptability is improved, but sperm fertility deteriorates

Engineering Contradiction:
Improvesperm transport and storage capabilityVSAvoidsperm fertility
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying the biochemical environment of the sperm through the addition of specific compounds. These compounds change the physiological parameters of sperm (such as intracellular cAMP concentration, membrane fluidity, and metabolic activity) to maintain fertility despite the cryopreservation process. The compounds adjust the sperm's biochemical state to be more resilient to freezing and storage conditions.

Inventive Principle:
Principle #35Parameter changes

3Duration of action of stationary object

If extenders are added to prolong semen half-life, then storage duration is improved, but sperm motility enhancement is not achieved

Engineering Contradiction:
Improvesemen half-lifeVSAvoidsperm motility enhancement
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent effectively copies or replicates the natural physiological conditions that maintain sperm motility by introducing compounds that mimic endogenous signaling molecules (such as cAMP elevating agents). Instead of relying solely on extenders that merely preserve sperm, these compounds actively replicate the biochemical signals necessary for maintaining and even enhancing motility during storage, going beyond simple preservation to active motility support.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS12616193B25-(1H-indol-3-yl)-oxazole, -oxadiazole and -furan derivatives as enhancers of sperm motility
Publication Date: 2026.05.05 SPERMATECH AS
  • US12616193B2 patent drawing
  • US12616193B2 patent drawing
  • US12616193B2 patent drawing

AI summary

The invention relates to the use of compounds of formula (I), stereoisomers, and physiologicaily tolerable salts thereof, to enhance the motility of sperm obtained from a non-human mammal: wherein in formula I: X is —NR′— (in which R′ is H or C1-3 alkyl. e.g. —CH3), —O—, —S— or —CH2—; Y is —S—, —O—, —NR″— (in which R″ is H or C1-3 alkyl, e.g. —CH3), or —CH2—; Z1 and Z2 are independently selected from N and CH; R1 to R3 are independently selected from hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, —OH, —CN, —NO2 and —NR12R13; R4 is hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, or —OH; R5 is hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, or C1-6 haloalkyl; R6 and R7 are independently selected from hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, —OH, —CN, —NO2 and —NR12R13; R8 is hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, —CN, —NO2 or —NR12R13; R9 is hydrogen or C1-4 alkyl; R10 and R11 are independently selected from hydrogen and C1-3 alkyl; or R10 and R11, together with the intervening —O— and ring atoms, are joined to form a dioxolane ring; and R12 and R13 are independently selected from H and C1-3 alkyl. The compounds find particular use in animal husbandry to increase the rate of fertilization in artificial insemination of livestock, especially pigs. They can also be used to prepare, pre-treat or store semen for use in artificial insemination procedures.